C46H45ClN4O5 — CID 6686655
N-[[2-[4-[(2S,4S,5R,6R)-4-[[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]methyl]-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]quinoxaline-2-carboxamide (PubChem CID 6686655) has the molecular formula C46H45ClN4O5 and a molecular weight of 769.34 g/mol. Its IUPAC name is N-[[2-[4-[(2S,4S,5R,6R)-4-[[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]methyl]-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]quinoxaline-2-carboxamide.
| Compound Name | N-[[2-[4-[(2S,4S,5R,6R)-4-[[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]methyl]-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]quinoxaline-2-carboxamide |
|---|---|
| PubChem CID | 6686655 |
| Molecular Formula | C46H45ClN4O5 |
| Molecular Weight | 769.34 g/mol |
| Exact Mass | 768.31 |
| IUPAC Name | N-[[2-[4-[(2S,4S,5R,6R)-4-[[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]methyl]-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]quinoxaline-2-carboxamide |
| SMILES | C[C@H]1[C@@H](CN2CCC(O)(c3ccc(Cl)cc3)CC2)O[C@@H](c2ccc(-c3ccccc3CNC(=O)c3cnc4ccccc4n3)cc2)O[C@H]1c1ccc(CO)cc1 |
| InChI | InChI=1S/C46H45ClN4O5/c1-30-42(28-51-24-22-46(54,23-25-51)36-18-20-37(47)21-19-36)55-45(56-43(30)33-12-10-31(29-52)11-13-33)34-16-14-32(15-17-34)38-7-3-2-6-35(38)26-49-44(53)41-27-48-39-8-4-5-9-40(39)50-41/h2-21,27,30,42-43,45,52,54H,22-26,28-29H2,1H3,(H,49,53)/t30-,42+,43+,45+/m0/s1 |
| InChIKey | VYMWPAGSHFJAOZ-XYVAZAFTSA-N |
| XLogP | 8.15 |
| TPSA | 117.04 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 56 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 769.34 |
| LogP ≤ 5 | 8.15 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |